• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Poult Sci . CRISPR/Cas13a-based genome editing for establishing the detection method of H9N2 subtype avian influenza virus

tetano

Editor, Senior Moderator
Poult Sci


. 2024 Jul 9;103(10):104068.
doi: 10.1016/j.psj.2024.104068. Online ahead of print. CRISPR/Cas13a-based genome editing for establishing the detection method of H9N2 subtype avian influenza virus

Sha-Sha Chen[SUP] 1 [/SUP], Yong-Lei Yang[SUP] 1 [/SUP], Hong-Yun Wang[SUP] 1 [/SUP], Tian-Kui Guo[SUP] 1 [/SUP], Riaz-M Azeem[SUP] 1 [/SUP], Chun-Wei Shi[SUP] 1 [/SUP], Gui-Lian Yang[SUP] 1 [/SUP], Hai-Bin Huang[SUP] 1 [/SUP], Yan-Long Jiang[SUP] 1 [/SUP], Jian-Zhong Wang[SUP] 1 [/SUP], Xin Cao[SUP] 1 [/SUP], Nan Wang[SUP] 1 [/SUP], Yan Zeng[SUP] 1 [/SUP], Wen-Tao Yang[SUP] 2 [/SUP], Chun-Feng Wang[SUP] 3 [/SUP]



Affiliations
Free article Abstract

Avian influenza virus (AIV) subtype H9N2 has significantly threatened the poultry business in recent years by having become the predominant subtype in flocks of chickens, ducks, and pigeons. In addition, the public health aspects of H9N2 AIV pose a significant threat to humans. Early and rapid diagnosis of H9N2 AIV is therefore of great importance. In this study, a new method for the detection of H9N2 AIV based on fluorescence intensity was successfully established using CRISPR/Cas13a technology. The Cas13a protein was first expressed in a prokaryotic system and purified using nickel ion affinity chromatography, resulting in a high-purity Cas13a protein. The best RPA (recombinase polymerase amplification) primer pairs and crRNA were designed and screened, successfully constructing the detection of H9N2 AIV based on CRISPR/Cas13a technology. Optimal concentration of Cas13a and crRNA was determined to optimize the constructed assay. The sensitivity of the optimized detection system is excellent, with a minimum detection limit of 10° copies/μL and didn't react with other avian susceptible viruses, with excellent specificity. The detection method provides the basis for the field detection of the H9N2 AIV.

Keywords: CRISPR/Cas13a; RPA; SHERLOCK; avian influenza virus; detection.

 
Back
Top Bottom